Feasibility Study of the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR)
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 65
- Locations
- 2
- Primary Endpoint
- Recommendations for Cancer Surveillance (Patient-reported Outcomes From the Survivor Self-Assessment)
Study Overview
Brief Summary
This study is being done to understand how survivors of head and neck cancer think they can make HN-STAR (the Survivor Self-Assessment, the survivorship clinic experience, and the Survivorship Care Plan the best it can be. Once the investigators have your input and input from other survivors, they can make changes to HN-STAR, so that they can test this tool in a larger study. The larger study will tell them whether using HN-STAR improves the care of head and neck cancer survivors.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Aim 1: Part 1
- •Have completed treatment for head and neck cancer at least 1 year prior to survivorship visit and have no evidence of disease
- •Have a primary care provider
- •Be able to provide informed consent
- •Be able to speak and read English
- •Be at least 18 years old
- •Aim 1: Part 2
- •Have completed treatment for head and neck cancer at least 1 year prior to survivorship visit and have no evidence of disease
- •Have a primary care provider
- •Be able to provide informed consent
- •Be able to speak and read English
- •Be at least 18 years old
Exclusion Criteria
- •Aim 1: Parts 1 and 2 is the same
- •Patients or providers who cannot speak or read English
- •Patients with cognitive, visual, or motor impairment such that they cannot complete the Survivor Self-Assessment as assessed by the research team.
Outcomes
Primary Outcomes
Recommendations for Cancer Surveillance (Patient-reported Outcomes From the Survivor Self-Assessment)
Time Frame: 2 years
Using data from survivors in Aim 1: Part 2 (N=45), we will abstract data on health care actions from both the medical record and HN-STAR. Such data include receipt of appropriate oncologic surveillance, identification and management of symptoms, and appropriate preventive health services, as indicated by referrals, prescriptions, and recommendations in both clinic notes and the HN-STAR Survivor Self-Assessment. For each participant, HN-STAR generates a Treatment Summary/TS for the clinician to review and verify its accuracy compared with clinical documentation with the participant medical record.
Secondary Outcomes
No secondary outcomes reported